ABCB1 and COVID-19: We addressed this concern in two ways, as follows: functionally, by using chemical inhibition of MDR1 in human airway models, and transcriptionally, by determining the expression of ABCB1 in HAEC or in cells obtained from BAL of healthy or COVID-19 patients.